IP Library Granted Patent US 8,632,823
Granted Patent B2
US 8,632,823 · App. 11/962,464 · Granted Jan 21, 2014

Treatment of infected tissues with hypochlorous acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,632,823
App. No.
11/962,464
Granted
Jan 21, 2014
Kind
B2
Abstract

Super-oxidized water based on hypochlorous acid, such as is obtained by the electrochemical treatment of a saline solution, may be used in the treatment of leg ulcers or other open wounds. Preferably, the pH of the super-oxidized water is in a range of 4 to 7, and the water has a redox potential of >950 mV. Medicaments based on the super-oxidized water may be in liquid or gel form. The super-oxidized water is able to control the microbial population within the wound and at the same time permit cell proliferation.

Claims (10)

1. A method for disinfecting a mammalian tissue comprising dermal fibroblasts, the method comprising:

administering a hypochlorous acid formulation to said tissue in an amount effective to act as a microbiocide without inhibiting growth of said dermal fibroblasts;

wherein the formulation is obtained by (i) electrolysis of an aqueous saline solution to provide an output hypochlorous acid solution having an available free chlorine concentration of 144 mg/L to 400 mg/L and a redox potential of >950 mV, and (ii) diluting said output solution and adjusting its pH such that the pH is within 5 to 7.

2. The method of claim 1 , wherein the mammalian tissue comprises a surface or open wound.

3. The method of claim 2 , wherein the mammalian tissue comprises a leg ulcer.

4. The method of claim 1 , wherein the mammalian tissue comprises a burn.

5. The method of claim 3 or 4 , wherein the formulation has a pH of about 5.4 or about 6.2.

6. The method of claim 1 , wherein the formulation is formulated as a gel.

7. The method of claim 1 , wherein the output hypochlorous acid solution is produced in an electrochemical cell having electrodes separated by a semi-permeable membrane.

8. The method of claim 1 , wherein the mammalian tissue further comprises keratinocytes.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2019
From: REALM THERAPEUTICS, INC.
To: URGO US, INC.
Reel/Frame 049405/0191 →
CHANGE OF NAME Recorded Jan 5, 2017
From: PURICORE, INC.
To: REALM THERAPEUTICS, INC.
Reel/Frame 041268/0225 →
RELEASE OF SECURITY INTEREST Recorded Mar 17, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: PURICORE, INC.
Reel/Frame 038019/0196 →
SECURITY AGREEMENT Recorded Jan 27, 2014
From: PURICORE, INC.
To: SQUARE 1 BANK
Reel/Frame 032126/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2011
From: PURICORE INTERNATIONAL LIMITED
To: PURICORE, INC.
Reel/Frame 025644/0164 →